EastPharma Ltd. GDR | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
217,125.20
210,532.90
209,888.10
224,917.10
220,429.60
233,923.20
Cost of Goods Sold (COGS) incl. D&A
138,175.40
139,642.60
125,942.80
131,336.90
120,514.50
115,550.80
Gross Income
78,949.80
70,890.20
83,945.30
93,580.20
99,915.10
118,372.40
SG&A Expense
64,482.10
54,558.70
50,017.80
51,726.50
51,936.10
47,041.30
EBIT
14,467.60
16,331.60
33,927.50
41,853.70
47,979.10
71,331.10
Unusual Expense
466.70
852.60
4,173.30
3,047.50
7,009.50
10,061.30
Non Operating Income/Expense
23,010.80
1,315.00
742.50
1,420.80
3,328.20
1,946.50
Interest Expense
13,768.20
18,261.50
16,344.10
16,411.70
15,028.80
22,709.90
Pretax Income
1,977.40
1,550.60
14,672.20
24,261.40
30,191.00
41,268.30
Income Tax
453.90
407.70
2,798.30
5,793.90
2,368.60
7,106
Equity in Affiliates
461.10
407.30
553.80
-
-
-
Consolidated Net Income
1,062.40
1,550.20
11,320.00
18,467.50
27,822.40
34,162.30
Net Income
529.40
1,617.90
8,699.70
15,371.70
23,485.70
29,176.70
Net Income After Extraordinaries
529.40
1,617.90
8,699.70
15,371.70
23,485.70
29,176.70
Net Income Available to Common
529.40
1,617.90
8,699.70
15,371.70
23,485.70
29,176.70
EPS (Basic)
0.01
0.02
0.13
0.23
0.35
0.43
Basic Shares Outstanding
67,650.00
67,650.00
67,650.00
67,650.00
67,650.00
67,650
EPS (Diluted)
0.01
0.02
0.13
0.23
0.35
0.43
Diluted Shares Outstanding
67,650.00
67,650.00
67,650.00
67,650.00
67,650.00
67,650
EBITDA
33,856.00
33,944.50
49,001.80
56,759.20
57,416.20
78,963.60
Non-Operating Interest Income
24,755.30
841.80
519.60
446.10
922.10
761.90
Minority Interest Expense
1,591.80
67.80
2,620.30
3,095.80
4,336.70
4,985.60
About EastPharma
View Profile
